Moneycontrol PRO
HomeNewsTrendsHealthNew COVID-19 cases hover below 10k mark for fifth day in a row; active infections under 70k

New COVID-19 cases hover below 10k mark for fifth day in a row; active infections under 70k

Bihar and Meghalaya were the only two states to report a nominal rise in active coronavirus infections

March 04, 2022 / 09:48 IST
Representative image

Representative image

Fresh COVID-19 cases in India stayed under the 10,000 mark for the fifth day, down 2.5 per cent over 24 hours at 6,396 even as active infections kept falling.

The new cases take the total confirmed tally in the country to 4,29,51,556.

A total of 201 COVID-19 deaths were also registered in the past 24 hours, taking the toll due to the infectious disease to 5,14,388. Kerala continued to report backlog deaths as part of its data reconciliation exercise, registering 88 backlog deaths.

It also registered the most deaths at 73 followed by Maharashtra (12) in the 24-hour period.

The active COVID-19 caseload in the country now stands at 69,897—down over nine per cent from the previous day and 0.16 per cent of the total confirmed cases. Active coronavirus cases in Kerala, which has the highest caseload in the country, are now under 20,000.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The daily test positivity rate in India stood at 0.69 per cent, while the rolling average of the weekly positivity rate came down to 0.90 per cent.

Bihar and Meghalaya were the only two states which reported a nominal rise in active coronavirus infections.

States cumulatively registered 13, 450 recoveries in the last 24 hours, raising total recoveries to 4,23,67,070 with the recovery rate reaching 98.64 per cent.

The health ministry said that a total of 77.09 crore tests have been conducted in the country so far of which 9,23,351 tests were carried out in the last 24 hours.

Overall, 178.29 crore vaccine doses have also been administered under the nationwide vaccination drive against coronavirus, as per details shared.

 

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Mar 4, 2022 09:48 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347